Tacrolimus Market Size

Tacrolimus Market Size

Tacrolimus Market size was valued at USD 6.6 billion in 2023 and is expected to expand at a CAGR of 5.6% between 2024 and 2032. The rising number of organ transplant procedures and the increasing prevalence of autoimmune diseases are anticipated to be key drivers fueling the growth of the market.

To get key market trends

  Download Free Sample

The significant increase in the number of organ transplant procedures is attributed to various factors such as the increasing prevalence of end-stage organ failure, heightened awareness about organ donation, and advancements in procedural technology, among others. Conditions such as chronic kidney disease, liver cirrhosis, and heart failure, driven by aging populations and lifestyle-related diseases, have spurred the demand for transplantation as a life-saving measure.

For instance, according to the United Network for Organ Sharing (UNOS), the U.S. recorded a record-breaking 42,887 organ transplant procedures in 2022, with over 14,000 deceased organ donors contributing to more than 36,400 transplants. These statistics underscore the global efforts and advancements in organ donation and transplantation, indicating a promising trajectory for the tacrolimus market.
 

Tacrolimus is a medication belonging to the class of drugs known as calcineurin inhibitors. It is primarily used in organ transplant recipients to prevent rejection of the transplanted organ by suppressing the immune system.